In our study, patients with PvB19 related PRCA had significantly lower counts of CD3+, CD4+, CD8+, CD4+CD45RO+, and CD8+CD45RO+ T lymphocyte and CD19+ B lymphocyte on the 5th month posttransplant. This evidence concerns the gene CD8A and pure red-cell aplasia.